Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
Matthias Kern(Unknown), Matthias Blüher(Helmholtz Centre for Environmental Research), Nora Klöting(Helmholtz Centre for Environmental Research), Detlef Stiller(Boehringer Ingelheim (Germany)), Michael Mark(Boehringer Ingelheim (Germany)), Thomas Klein(Central Institute for Art History), Heiko G. Niessen(Boehringer Ingelheim (Germany)), Leo Thomas(Boehringer Ingelheim (Germany))
Cited by 110
Related Papers
Obesity: global epidemiology and pathogenesis
|Nature Reviews Endocrinology|2019|5.1k
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
|New England Journal of Medicine|2008|2.1k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k